Health And Medicine
-
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. Read MoreDec 4, 2023
-
HRSA awards $4 million to VUSN to address need for nurse-midwives and access to care
Vanderbilt University School of Nursing has received a $4 million grant from the Health Resources and Services Administration to increase and diversify the nurse-midwife workforce as a means of improving maternal health and increase access to care. The school will use the Maternity Care Nursing Workforce Expansion grant to educate nurse-midwifery students with a specialized curriculum and community-based clinical experiences focused on providing care in rural and underserved communities. Read MoreNov 30, 2023
-
Nonprofits support quest to cure childhood epilepsy
Monica Joanna Elnekaveh was doing everything she could to learn what was causing her 18-month-old daughter’s developmental issues. Her relentless quest to find answers eventually led her to Vanderbilt investigative neurologist Jing-Qiong (Katty) Kang, MD, PhD. Read MoreNov 29, 2023
-
School of Nursing secures Moore Foundation grant for leadership academy
Boosting its commitment to underrepresented nursing leaders, Vanderbilt University School of Nursing has secured a grant from the Gordon and Betty Moore Foundation for its innovative leadership program, Academy for Diverse Emerging Nurse Leaders. The academy is a groundbreaking, five-day immersive fellowship specially designed to train nurses from backgrounds that are underrepresented in nursing leadership... Read MoreNov 29, 2023
-
Vanderbilt hosts Tennessee lawmakers, showcases research and innovation that support veterans, active military
The group got an overview of Vanderbilt’s programs that support veterans and of the university’s robust research partnership with the U.S. Department of Defense and Fort Campbell. Read MoreNov 22, 2023
-
VUMC scientists discover key step to kidney fibrosis
Researchers at Vanderbilt University Medical Center for the first time have shown that activation of the epidermal growth factor receptor (EGFR) is essential for the development of kidney fibrosis, tissue scarring following injury that can lead to kidney failure. Read MoreNov 21, 2023
-
Vanderbilt’s Dr. W. Kimryn Rathmell to be appointed director of the National Cancer Institute
Kimryn Rathmell, MD, PhD, MMHC, the Hugh Jackson Professor of Medicine and chair of the Department of Medicine at Vanderbilt University Medical Center, will be appointed Director of the National Cancer Institute. Read MoreNov 17, 2023
-
Tumor antigens key to improving cancer immunotherapy: study
Vanderbilt researchers are working to better design immune therapies that attack tumors without also attacking healthy normal tissue in patients. Read MoreNov 17, 2023
-
New collaborative research project seeks improved treatment for cystic fibrosis
Lars Plate, assistant professor of chemistry and biological sciences, has received a $2.76 million collaborative grant to investigate medical therapy for people with cystic fibrosis. The interdisciplinary project brings together teams with varied expertise in computational structural biology, proteomics, biophysics, and physiology in hopes of improving the quality of life for those afflicted with the genetic disease. Read MoreNov 16, 2023
-
Twelve at Vanderbilt are among world’s highly cited researchers
Twelve current investigators at Vanderbilt University Medical Center and Vanderbilt University are on this year’s list of scientists whose papers have been cited the most frequently by other researchers. Read MoreNov 15, 2023
-
Novel C. diff structures are required for infection, offer new therapeutic targets
Vanderbilt research discovers that iron storage “spheres” inside the bacterium C. diff — the leading cause of hospital-acquired infections — are important for infection in an animal model and could offer new targets for antibacterial drugs. Read MoreNov 15, 2023
-
Most can lower blood pressure by reducing salt, even those on BP drugs: study
New research shows nearly everyone can lower their blood pressure, even people currently on blood pressure- reducing drugs, by lowering their sodium intake. Read MoreNov 13, 2023
-
Study links gene network and pancreatic beta cell defects to Type 2 diabetes
A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to Type 2 diabetes. Read MoreNov 8, 2023
-
Anxiety Sensitivity: ‘What If’ Fears Impact Care for ICU Patients, During and After Hospitalization
Clinicians need to have a better understanding of the potential impact of patients’ anxiety sensitivity, or “fear of fear,” according to an article published in American Journal of Critical Care. When a patient has anxiety sensitivity, they misinterpret nonthreatening symptoms as threatening, assessing the potential meaning across physical, social or cognitive domains. These “what if” thoughts may trigger a spiral effect, stimulating the nervous system and resulting in stronger sensations and further catastrophic misinterpretations. Read MoreNov 8, 2023
-
Children’s antibodies highly potent against COVID-19: study
Reporting Nov. 6 in Cell Reports Medicine, Ivelin Georgiev, PhD, and colleagues demonstrated that antibodies isolated from children’s blood samples displayed high levels of neutralization and potency against variants of the COVID-19 virus, SARS-CoV-2, even when the children had not previously been exposed to or vaccinated against those variants. Read MoreNov 6, 2023
-
Kimryn Rathmell wins Doris Duke Foundation Paragon Award
Kimryn Rathmell, MD, PhD, chair of Medicine at Vanderbilt University Medical Center, has received the Paragon Award for Research Excellence from the Doris Duke Foundation. Read MoreNov 2, 2023
-
Pancreas “crosstalk” may influence course of Type 1 and Type 2 diabetes
In the largest study of its kind, researchers at Vanderbilt have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms of diabetes, and with aging and obesity. Read MoreNov 1, 2023
-
Osheroff receives Distinguished Teacher Award from Association of American Medical Colleges
As a professor of biochemistry and medicine at Vanderbilt University School of Medicine for more than 40 years, Osheroff is the longest serving course director currently teaching medical students. He also codirects the preclerkship phase of the medical school curriculum and leads the Master Science Teachers cohort, a role established in 2007 to recognize VUSM’s outstanding basic science educators. Through his teaching, he has helped medical students at VUSM and across the globe acquire the basic science skills and knowledge they need to thrive in clinical practice, according to the AAMC. Read MoreOct 31, 2023
-
Crowe, Osheroff honored by AAMC
Vanderbilt's James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event. Read MoreOct 30, 2023